Archives
-
Peroxynitrite, Calcium Flux, and Cardiac Necroptosis
2026-10-04
Liu et al. identify a mechanistic connection between hyperhomocysteinemia, peroxynitrite, ER-to-mitochondria calcium transfer, and cardiac microvascular endothelial-cell necroptosis during ischemia–reperfusion injury. The study supports IP3R-dependent calcium handling as a candidate therapeutic pathway, while its cell and animal models define important limits on clinical interpretation.
-
EZ Cap™ Firefly Luciferase mRNA as a Delivery Readout
2026-10-03
EZ Cap™ Firefly Luciferase mRNA can function as more than a bioluminescent reporter: it offers a framework for separating payload competence from nanoparticle delivery biology. This article interprets its Cap1 and poly(A) design alongside recent lung-targeting LNP evidence, with emphasis on what luminescence can—and cannot—prove.
-
Molecular Stratification of RNA-Lipid Nanoparticles
2026-10-02
This 2025 Communications Chemistry study introduces cryogenic Orbitrap secondary ion mass spectrometry (Cryo-OrbiSIMS) for label-free molecular depth profiling of RNA-loaded lipid nanoparticles. By combining Cryo-TEM with fragment-specific depth analysis, the authors show that PEG-containing fragments occupy the particle surface while DMG-associated fragments are located deeper near the RNA-rich core, providing direct evidence for lipid stratification and orientation.
-
Ceramides Drive RGNNV Infection Through Autophagy
2026-10-01
A 2026 Journal of Virology study combines global lipidomics with pathway perturbation to show that ceramide accumulation promotes red-spotted grouper nervous necrosis virus replication. The work identifies capsid-protein-associated ceramide remodeling and autophagy as experimentally tractable features of RGNNV infection, while highlighting important limits for translation beyond fish cells.
-
Quercetin-Glycoside LNPs Reduce mRNA Inflammation
2026-10-01
The 2026 Chemical Engineering Journal study developed quercetin-glycoside-incorporated lipid nanoparticles that improved in vivo mRNA delivery while reducing inflammatory responses. Quercetin di-glucoside at a 30 mol% substitution produced a formulation with stronger lymph-node transfection, dendritic-cell activation, and SARS-CoV-2 mRNA-driven adaptive immunity than conventional LNPs.
-
NGFR100W mRNA-LNPs for Peripheral Neuropathy
2026-09-30
The reference study combines codon and signal-peptide engineering with N1-methylpseudouridine-modified mRNA and lipid nanoparticles to produce a less nociceptive NGF variant in vivo. Its results show how transient mRNA expression can support axon growth, reduce pain-related activity, and accelerate recovery of intraepidermal nerve fibers in a paclitaxel-induced neuropathy model.
-
D-Lin-MC3-DMA and Translational mRNA Delivery
2026-09-30
Dlin-MC3-DMA is an ionizable cationic liposome lipid for controlled nucleic-acid delivery. This article connects its formulation logic to a 2025 SDF-1α mRNA peripheral artery disease study and translates the findings into practical assay decisions.
-
Imipramine Workflows for Autophagy Research
2026-09-29
Build a controlled Imipramine workflow that separates transporter potency from cell-state effects in glioma, leukemia, neuronal, and immune models. The framework combines autophagy flux, apoptosis, viability, and lipid measurements so a single endpoint is not mistaken for mechanism.
-
Phenacetin in Human Organoid Pharmacokinetics
2026-09-29
A translational strategy for using Phenacetin as a defined test article in human pluripotent stem cell-derived intestinal organoids, integrating chemical properties, epithelial metabolism, assay design, reproducibility, and responsible interpretation.
-
Imipramine: Autophagy and Apoptosis Workflows
2026-09-28
Imipramine offers a practical pharmacological entry point for connecting autophagy, apoptosis, and cell-state phenotyping. This workflow shows how to evaluate it in glioma and leukemia models while using ceramide-focused virology findings to guide, but not overstate, exploratory antiviral assays.
-
Ceapin-A7 for ATF6α: A Tool for Causal ER-Stress Tests
2026-09-28
Ceapin-A7 is a selective ER stress blocker for isolating ATF6α signaling from broader unfolded protein response effects. This article shows how to use it as a mechanistic probe—and how to interpret it alongside findings from glucocorticoid-induced osteonecrosis research without assuming an unproven pathway connection.
-
HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus
2026-09-27
The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus supports in vitro transcription of fluorescent RNA probes for workflows such as in situ hybridization and Northern blotting. It is intended for research use only; follow the kit instructions for reaction conditions, and do not use it for diagnostic, clinical, or therapeutic purposes.
-
Cy3 Goat Anti-Human IgG (H+L) Antibody Workflows
2026-09-26
Turn human-IgG binding into a bright fluorescence readout across cell imaging, tissue staining, flow cytometry, and ELISA. This practical guide also explains a key limitation for orthopoxvirus studies: the reagent detects human IgG, not the mouse monoclonal antibodies used in the featured research.
-
STING agonist-1: Practical B-Cell Assay Workflows
2026-09-25
Use STING agonist-1 to test how STING-pathway perturbation shapes B-cell signaling, IRF4 responses, and ESCC-relevant immune models. This guide separates exploratory assay conditions from published findings and offers workflow choices for interpreting STING–CD40 crosstalk without treating a research reagent as a validated therapy.
-
Sulfo-Cy3 NHS Ester: From Labeling to Vascular Insight
2026-09-25
How hydrophilic fluorescent labeling can help translational researchers interrogate vascular-remodeling mechanisms—without confusing a useful imaging tool with proof of biological function.